Cartesian Prices $200M IPO amidst the Week’s Wreckage

by | May 6, 2022

A SPAC IPO to end a rough week. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

SPAC IPO: RENEU

Cartesian Growth Corp.II (RENEU) priced a $200M IPO. $10.30 in cash in trust. The SPAC will focus on “established high-growth companies that operate in a manner consistent with the United Nations Principles for Responsible Investment.”  The Company’s sponsor is an affiliate of Cartesian Capital Group, a global private equity firm specializing in providing growth capital to transnational businesses. Cartesian Growth Corp. II is led by Chairman and CEO Peter Yu, and CFO Beth Michelson.

DKDCA Extends

Data Knights Acquisition Corp. (DKDCA) extends until August. SPAC adds $0.10 to trust. NAV ~$10.30.

Elsewhere in SPACs

Upcoming Events

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

Recent Analysis

Daily SPAC Update – May 1, 2025

Two SPAC IPOs to Start May — Republic Digital Upsized to $264M and Copley at $150M. ClimateRock Extension Vote. Aimfinity Delisting. Distoken Deal Vote Postponed.

Daily SPAC Update – April 30, 2025

AltEnergy Extends to May 2026. ClimateRock, Healthcare AI, Clean Energy Special Situations Extension Votes. Distoken and Chenghe Postpone Deal Votes.

Daily SPAC Update – April 29, 2025

Black Hawk Deal with Vesicor Therapeutics. Integrated Rail & Resources and Rigel Resource Set Extension Votes. Healthcare AI Acquisition Adjourns Vote to April 30.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.